Vertex Pharmaceuticals Incorporated (VRTX)

NASDAQ: VRTX · Real-Time Price · USD

515.55

+9.80 (1.94%)

At close: Aug 17, 2026, 4:00 PM EDT

518.92

+3.37 (0.65%)

After-hours: Aug 17, 2026, 6:39 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Trikafta / Kaftrio Revenue	10.08B	10.31B	10.24B
Alyftrek Revenue	1.63B	837.80M	-
Casgevy Revenue	190.50M	115.80M	10.00M
Journavx Revenue	124.90M	59.60M	-
Other Product Revenue	-	820.10M	781.50M
Net Product Revenue	12.59B	11.97B	11.02B
Other Collaborative and Royalty Revenue	-	30.70M	-
Revenue (Total)	12.59B	12.00B	11.02B

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Other Collaborative and Royalty Revenue	-	30.70M	-
United States Product Revenue	7.90B	7.55B	6.68B
Outside of United States Product Revenue	4.72B	4.45B	4.34B
Revenue (Other)	-30.70M	-30.70M	-
Revenue (Total)	12.59B	12.00B	11.02B